{"transactions":[{"id":853833,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":62053,"kind":"person","name":"Harmon Seth","position":1,"cik":"0001993300","reported_name":"Harmon Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-09T19:49:36.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2031,"price":30.19,"value":61315.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amendment corrects the number of shares and price sold to cover taxes on the initial Form 4 filed on March 4, 2026, as well as the resulting total number of shares beneficially owned following all transactions reported in the initial Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amendment corrects the number of shares and price sold to cover taxes on the initial Form 4 filed on March 4, 2026, as well as the resulting total number of shares beneficially owned following all transactions reported in the initial Form 4."}],"balance_after":7850,"source":{"system":"sec-edgar","filing":"0001193125-26-099023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993300/000119312526099023/ownership.xml","form_type":"4/A","original_submission_date":"2026-03-04"}},{"id":862181,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":62053,"kind":"person","name":"Harmon Seth","position":1,"cik":"0001993300","reported_name":"Harmon Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T19:15:18.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":6267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 3, 2025, subject to the Reporting Person's continued service to Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 3, 2025, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":18801,"derivative":{"underlying":"Common Stock","underlying_shares":6267},"source":{"system":"sec-edgar","filing":"0001193125-26-092071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1993300/000119312526092071/ownership.xml","form_type":"4"}},{"id":862180,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":62053,"kind":"person","name":"Harmon Seth","position":1,"cik":"0001993300","reported_name":"Harmon Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T19:15:18.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":20550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 2, 2026, subject to the Reporting Person's continued service to Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 2, 2026, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":20550,"derivative":{"underlying":"Common Stock","underlying_shares":20550},"source":{"system":"sec-edgar","filing":"0001193125-26-092071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1993300/000119312526092071/ownership.xml","form_type":"4"}},{"id":862179,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":62053,"kind":"person","name":"Harmon Seth","position":1,"cik":"0001993300","reported_name":"Harmon Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T19:15:18.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":102850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in 48 equal monthly installments following the date of the grant, subject to the Reporting Person's continued service to Issuer through each vesting date.  The date of the grant is March 2, 2026."}],"balance_after":102850,"derivative":{"exercise_price":30.25,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":102850},"source":{"system":"sec-edgar","filing":"0001193125-26-092071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1993300/000119312526092071/ownership.xml","form_type":"4"}},{"id":862178,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":62053,"kind":"person","name":"Harmon Seth","position":1,"cik":"0001993300","reported_name":"Harmon Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-04T19:15:18.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2091,"price":29.32,"value":61308.12,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 903 shares acquired on March 17, 2025 under Viridian Therapeutics, Inc.'s 2016 Employee Stock Purchase Plan and 1,000 shares acquired on September 17, 2025 under Viridian Therapeutics, Inc.'s 2025 Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c)."}],"balance_after":7790,"source":{"system":"sec-edgar","filing":"0001193125-26-092071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1993300/000119312526092071/ownership.xml","form_type":"4"}},{"id":862177,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":62053,"kind":"person","name":"Harmon Seth","position":1,"cik":"0001993300","reported_name":"Harmon Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-04T19:15:18.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":6267,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 903 shares acquired on March 17, 2025 under Viridian Therapeutics, Inc.'s 2016 Employee Stock Purchase Plan and 1,000 shares acquired on September 17, 2025 under Viridian Therapeutics, Inc.'s 2025 Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c)."}],"balance_after":9881,"source":{"system":"sec-edgar","filing":"0001193125-26-092071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993300/000119312526092071/ownership.xml","form_type":"4"}},{"id":1229765,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":62053,"kind":"person","name":"Harmon Seth","position":1,"cik":"0001993300","reported_name":"Harmon Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T21:12:50.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":25068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 3, 2025, subject to the Reporting Person's continued service to Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, March 3, 2025, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":25068,"derivative":{"underlying":"Common Stock","underlying_shares":25068},"source":{"system":"sec-edgar","filing":"0000950170-25-032884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1993300/000095017025032884/ownership.xml","form_type":"4"}},{"id":1229764,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":62053,"kind":"person","name":"Harmon Seth","position":1,"cik":"0001993300","reported_name":"Harmon Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-04T21:12:50.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":150407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in 48 equal monthly installments following the date of the grant, subject to the Reporting Person's continued service to Issuer through each vesting date.  The date of the grant is March 3, 2025."}],"balance_after":150407,"derivative":{"exercise_price":14.41,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":150407},"source":{"system":"sec-edgar","filing":"0000950170-25-032884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993300/000095017025032884/ownership.xml","form_type":"4"}},{"id":1744303,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":62053,"kind":"person","name":"Harmon Seth","position":1,"cik":"0001993300","reported_name":"Harmon Seth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-13T17:17:05.000Z","date":"2023-11-10","kind":"grant","planned":false,"acquired":true,"shares":270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments through November 10, 2027, subject to the Reporting Person's continued service to Issuer through each vesting date."}],"balance_after":270000,"derivative":{"exercise_price":13.76,"expiration_date":"2033-11-10","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0000950170-23-063124","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993300/000095017023063124/ownership.xml","form_type":"4"}}]}